Introduction
cerebral damage are unlikely to respond to such a simple measure. In the presence of cardiac or
Il faut cultiver son jardin, Voltaire.
respiratory disease the reduction of temperature may The introduction of FDA regulations governing help reduce oxygen consumption, carbon dioxide marketing of new drugs ensures children will cease production and cardiac output while helping the to endure the role of therapeutic orphans. However, child to settle. Paracetamol is used to reduce anaesthetists involved in the care of children have the symptoms caused by mild acute infections in always sought to define the pharmacokinetics and children. In such viral infections paracetamol results pharmacodynamics of drugs used in their practice.
in only a modest improvement in activity and Unfortunately, these studies have usually only been alertness. Mood, comfort, appetite and fluid intake undertaken for the newer or 'glamour' drugs, partly were not improved compared to controls (2, 3) . It is because of their ability to attract pharmaceutical assumed that the fever associated with infections funding for research. Common or 'garden' drugs such causes discomfort. This premise has not been as paracetamol have, until recently, been ignored. substantiated. Indeed treatment of fever may impair Paracetamol has been used in clinical practice for antibody production (4) and delays parasite clearance over one hundred years. Acetanilid, the parent time in children suffering malaria (5) . compound of paracetamol, was introduced in 1886.
Paracetamol is reported to be an effective antiToxicity related problems with acetanilid lead to pyretic at serum levels of 10-20 mg·l -1 (6, 7) . This the introduction of paracetamol (acetaminophen, Nrelationship between serum concentration and acetyl-p-amino-phenol) by von Mering in 1893. The temperature is loosely defined. Several papers have popularity of paracetamol over the nonsteroidal antidocumented time delays of 1-2 h between maximum inflammatory agents ascended after the reported plasma concentrations and maximum temperature association between Reye's syndrome and aspirin in reduction (6, 8) . It is logical that these time delays the 1980s (1). The drug is well tolerated, lacks many should occur, given that the effect site is the of the side effects of aspirin, is available without hypothalamus which must induce physiological prescription and is widely used in the management body changes to cause temperature reduction. The of children with pain or fever.
population pharmacodynamic parameters, however, have not been defined.
Pharmacodynamics of many biological systems can
Pharmacodynamics be defined using a sigmoid Emax model (9).
a) Antipyresis
Effect=E0+(Emax * Ce where E0 is the baseline response, Emax is the maximum effect change, Ce is the concentration in Temperatures above this caused by heat stroke or
b) Analgesia
Paracetamol is thought to have an analgesic effect on NMDA receptors in the spinal cord (11, 12) . It is assumed that analgesia occurs in a similar plasma paracetamol concentration range to that required for antipyresis (13) . This is unproven. The analgesic effect of paracetamol is thought to be directly related to its plasma concentration (14) because of its high lipid solubility and low protein binding in this concentration range (15 analgesic effect in rats using a sigmoid Emax model . The pharmacodynamics of paracetamol analgesia have not been adequately described in humans. Postoperative use of paracetamol in combination with the effect compartment, EC50 is the concentration opioids is reported to reduce opioid requirements by producing 50% Emax, and N is the Hill coefficient 16-26% after elective gynaecological laparotomies defining the steepness of the concentration-response (17). Adult human studies performed in volunteers curve. This model predicts no effect when no drug is demonstrated 0.5 g and 1 g immediate release present and is also capable of predicting a maximum paracetamol had analgesic effect superior to placebo effect the drug can achieve. Despite paracetamol use for one to five h, but no difference in analgesic effect for over 100 years, we do not know the maximum was noted between doses (18). The pain threshold temperature reduction (Emax) possible. Nor do we was significantly elevated compared to placebo one know the influence of covariates such as age and two h after paracetamol ingestion. The addition or disease process on pharmacodynamics. The of codeine 60 mg to paracetamol 1 g was superior to equilibration half-time (Teq), which is the link placebo one to six h after medication (19). These describing the relationship between the central studies also demonstrated a delay between maximum compartment and the effect compartment, is analgesia and peak plasma paracetamol concentraunknown. We are left with the loose undertions of an hour. The relationship between standing that temperature reduction occurs when concentration and effect cannot be as straightforward concentrations are in the range 10-20 mg·l −1 (6, 7) . and simple as that described in the rat model because Studies documenting concentration-temperature of these time delays. reduction hysteresis loops usually report naïve Paediatric studies using paracetamol 10 mg·kg
pooled data (6) . While it is possible to apply po have shown no more analgesic effect than pharmacokinetic-pharmacodynamic (PK-PD) modplacebo in children undergoing myringotomy (20) or elling techniques to such data, it is not possible suffering symptoms of tonsillitis and pharyngitis (21). to distinguish variability within individuals and Paracetamol 15 mg·kg −1 po given to unanaesthetized between individuals. The model is 'washed out' neonates undergoing circumcision was found not to by the data. A paracetamol pharmacodynamic ameliorate either intraoperative or immediate postconcentration-temperature reduction model for fever operative pain (22). Several recent papers (23,24) have has been described in children using pooled data investigated the analgesic efficacy of paracetamol ( Figure 1) (10 (24) showed a need to supplement rectal concentration-response curve may be quite different paracetamol 20 mg·kg -1 with a nonsteroidal antifrom that describing temperature reduction. A Hill inflammatory agent to achieve satisfactory analgesia. coefficient of only 0.5 has been postulated to describe The intravenous prodrug of paracetamol (prothe analgesic response (33) . Such a curve is shalpacetamol) 30 mg·kg −1 has been shown to give lower in its central portion, but steeper at low superior analgesia compared to placebo after concentrations when compared to that describing orthopaedic surgery (25).
fever control (Figure 1 ). Doubling the effect Most studies investigating paracetamol analgesia compartment concentration from 10 to 20 mg·1 −1 will have not included plasma paracetamol concentraresult in only a minor reduction of pain. tions as part of their analyses (20, 21, (24) (25) (26) (27) . The few
The estimation of population pharmacokineticstudies that have measured concentrations report pharmacodynamic parameters is difficult due to the them to be below 10 mg·l −1 after either the oral complexity of analgesic clinical trials and requires formulation 10-15 mg·kg −1 given four hourly (28) or advanced modelling techniques such as nonlinear a single rectal dose of 20 mg·kg −1 (13) . These poor mixed effect models (NONMEM) (34) . Placebo effect results may either reflect inadequate dosing and/ can contribute significant analgesia. Twenty-four or slow absorption of rectal paracetamol. Adequate percent of children received adequate analgesia analgesia in children undergoing tonsillectomy has after tonsillectomy despite no detectable plasma been described using acetaminophen 40 mg·kg −1 po paracetamol (30). However, the continuing use of preoperatively (29). In that study children were given placebo controls has been strongly argued against in either rectal or oral paracetamol in order to achieve the literature (35) . Pain intensity may change over the a spectrum of paracetamol concentrations and the study period. Patients who receive rescue medication analgesic assessment made at one fixed point in time.
and are withdrawn from a study introduce additional Fifty percent of children had satisfactory analgesia bias as the remaining study patients are those who at a concentration of 17 mg·l −1 (30). We would expect do not have such severe pain; the reason for their equivalent effect compartment concentrations to be reduced analgesia may not be solely pharmaceutical lower because of delayed onset of effects. (34, 36) . Pain relief measurements are nonrandomly Many clinical studies in which paracetamol is censored. Pain scores are often treated as continuous compared to another analgesic after a surgical insult rather than categorical data. In addition to these are destined to either fail to show a difference difficulties, pharmacodynamics may change with between the two analgesic treatments or to have age. Neonates, for example, may have altered inadequate power because pain score reporting pharmacodynamics when compared with older methods, the pain stimulus and pharmacokinetic children! parameters all have large variability.
Regardless of age-related pharmacodynamic Development of indirect measures of pain intensity changes, the drug must be administered 1-2 h before (e.g. measurement of transient changes in blood a surgical insult if an analgesic effect is to be achieved. flow by laser Doppler) will help decrease variability of effect measures. However pharmacokinetic variability remains. Prescott (31), in a study of 43 Pharmacokinetics adult convalescent patients, reported an 80 fold range a) General in concentrations one hour after three 500 mg tablets. Such variability will have impact on effect.
Pharmacokinetic studies in children are often limited Pharmacokinetic variability appears to have conby the small number of blood samples which can siderable impact on response rates for fever control be taken from an individual child. Data are often (32) . Similar considerations must certainly apply for presented as an average maximum concentration at analgesia and should be considered in the design an average maximum time (37, 38) . These confounded parameters (and the derived estimate of elimination and interpretation of clinical trials.
half-life) are highly dependent on sampling times. Pooled data may give an erroneous impression of results (39) . For example, Birmingham et al. (40) demonstrated that average peak concentrations of 5-6 mg·l −1 occurred at 240-300 min after rectal paracetamol, but the maximum mean concentration was 8.8 (SD 3.4) mg·l −1 and the time to maximum mean concentration was 288 (SD 126) min.
The measurement of urinary paracetamol and its metabolites has been used in children and neonates. Reasonable pharmacokinetic estimates have been made but the method is dependent on complete 
c) Absorption b) The impact of size
Paracetamol is a weak acid with a high pKa. In the Size has considerable impact on our interpretation alkaline medium of the duodenum paracetamol is of age-related pharmacokinetic changes. Size must nonionised. Consequently, absorption of the nonbe disentangled from age in order to understand ionised form in the duodenum is rapid. Brown et al. developmental changes in the young. Clearance is a (50) have reported rapid absorption (Tabs 2.7, se nonlinear function of size. The allometric 3 4 power 1.2 min; Tlag 4.2, se 0.4 min) parameters in febrile model is a more accurate predictor of size than the children (Figure 2 ). If these data can be reproduced per kilogram model for metabolic processes (43, 44) .
in children who have been subjected to a preoperative This model can be expressed as fast, then we would expect almost complete transit through the pylorus after 30 min. However, the effect X i =X std * (W i /W std ) PWR of preoperative paracetamol elixir on gastric contents has not been investigated. where X i is the parameter in the ith individual, W i is the weight in the ith individual and X std is the Rectal paracetamol is widely used in children presenting for surgical procedures because of parameter in an individual with a weight W std . The PWR parameter was 0.75 for clearance, 1 for gastrointestinal dysfunction or NPO policies. Several models have been used to describe rectal absorption. distribution volumes and 0.25 for half-lives (45) (46) (47) . In humans underprediction of clearance of Birmingham et al. (40) have reported a first order input model with a zero order dissolution time to more than 10% occurs at body weights less than 47 kg when the per kg model is used (44) .
describe absorption characteristics of acetaminophen suspended in a hydrogenated vegetable oil base. A Inappropriate size models for young children have led to misconceptions such as the enhanced capacity first order input model with a lag time has been used to describe absorption from glycogelatin capsules of children to metabolize drugs. This misconception has been demonstrated for the clearance of containing an acetaminophen slurry (51) . Regardless of the model or the suppository type, absorption is theophylline (48) and analgesics in children (49) . The There is reversal of the usual adult ratio of 2:1 glucuronide to sulphate conjugates of paracetamol in young children. This pattern reverts to adult pattern at the age of 12 years (56). However, we have few data concerning clearance in the very young or the speed of enzyme maturation.
Autret et al. (57), using an intravenous prodrug of acetaminophen, report a clearance (CL) of 4.5 l·h ) (58), as we would infants and children (38, 40, 51, 52) .
expect from the allometric size model with a power function of 1. The Vd/Foral appears to be similar even in neonates (76 l·70 kg 
e) Clearance
These data are supported by Sanderson et al. (62) . Perioperative plasma concentrations were measured Pharmacokinetic changes with age have received scant attention. We know that the manner in which at 24 h after a scheduled dosing regimen of 20 mg·kg −1 six hourly in children. The mean peak the liver metabolizes paracetamol changes with age. ·kg −1 recommendations. Alternatively paracetamol to older children by the age of one 30 mg·kg −1 may be given 8 hourly. These schedules year (10) . Dosage regimes recommended err on the are based on avoiding potential toxicity rather than cautious side (60 mg·day
) (8) again reflecting PK-PD considerations. Although the bioavailability the lack of well conducted pharmacokinetic studies. of rectal formulations are below those given orally, the upper dose limit for rectal formulations is the Toxicity same as oral as the medication is often charted either pr or po interchangeably and some children will a) Chronic use have a high relative bioavailability (Frectal/oral). The problem is that many children will have inadequate There has been a reticence among practitioners to prescribe higher doses of paracetamol (69). con centrations when paracetamol is administered rectally for analgesia using the 90 mg·day
Paracetamol overdose results in increased production of highly reactive electrophilic arylating metabolites regimen (32) . In the perioperative period, however, it may be possible to use a combination of by the hepatic cytochrome P-450-dependent mixed function oxidase enzyme system (70) . These preoperative oral and intraoperative rectal paracetamol to maintain a target concentration into metabolites bind to intracellular hepatic macromolecules to produce cell necrosis and damage. the recovery period.
Paracetamol may accumulate in paediatric patients after repeated therapautic doses (71 ·kg −1 for one to six days. Survival was usually seen in those children suffering P450 system (67) . However, the rate constant for the sulphation metabolic pathway is larger in neonates hepatotoxicity due to paracetamol greater than 150 mg·day −1 ·kg −1 for two to eight days. Current than in adults and is the most important route of metabolism (56) . This pathway is not related to guidelines (59,64) recommend that doses should not exceed 90 mg·day
, although a recent review serum bilirubin concentrations (68) . Single doses of 12-15 mg·kg −1 po achieve therapeutic serum suggests an even more conservative dose of 75 mg·day −1 ·kg −1 (74). concentrations (37, 68) . Autret et al. (57) , using an intravenous prodrug of The propensity for toxicity is increased by significant hepatic and renal disease, malnutrition paracetamol (propacetamol chlorhydrate) estimate a . The half-life was Paracetamol has been used as an antipyretic analgesic for over 100 years. Much has been learned about its less than four h in all patients without liver damage.
Clearance is a nonlinear function of weight. Dose pharmacokinetics in recent years. However, there are still huge gaps in our knowledge about this common is usually expressed as a linear function of weight. As a consequence younger children require larger drug. Paracetamol pharmacokinetics in the very young have yet to be elucidated. The problem of doses than older children and adults to achieve similar concentrations at four h. This has been cumulative toxicity with repeated dosing has not been addressed in this younger age group. We know demonstrated in animals. Young rats have a higher median lethal dose than older rats (77). More drug less about paracetamol pharmacodynamics at any age than we do about the newer synthetic opioids. is required to produce a hepatotoxic reaction (77).
Young children under the age of six years are Much work remains to be done defining population PK-PD relationships. The target concentration of thought to be less susceptible to toxicity than older children and adults (78). It is estimated that less than paracetamol is undefined. Studies using the intravenous prodrug of paracetamol (propacetamol) 5% of children under six years with paracetamol 
